|
|||||
|
|
Meta-analysis: Interleukin 6 gene -174G/C polymorphism associated with type 2 diabetes mellitus and interleukin 6 changes |
|
| Authors: | Hao Cheng Wenbin Zhu Mou Zhu Yan Sun Xiaojie Sun Di Jia Chao Yang Haitao Yu Chunjing Zhang |
| Affiliation: | 1. Department of Clinics, Qiqihar Medical University, Qiqihar, China Contribution: Data curation (equal), Formal analysis (equal), Writing - original draft (lead);2. Department of Molecular Biology Laboratory, Qiqihar Medical University, Qiqihar, China Contribution: Data curation (lead), Writing - original draft (equal);3. Department of Biochemistry and Molecular Biology, Qiqihar Medical University, Qiqihar, China Contribution: Methodology (lead);4. Department of Clinical Pathogen Microbiology, Qiqihar Medical University, Qiqihar, China Contribution: Methodology (equal), Project administration (equal);5. Department of Clinical Biochemistry, Qiqihar Medical University, Qiqihar, China Contribution: Methodology (equal), Project administration (equal);6. Department of Biochemistry and Molecular Biology, Qiqihar Medical University, Qiqihar, China Contribution: Project administration (lead);7. Department of Biochemistry and Molecular Biology, Qiqihar Medical University, Qiqihar, China Contribution: Data curation (equal), Project administration (equal);8. Department of Cell Biology, Qiqihar Medical University, Qiqihar, China;9. Department of Biochemistry and Molecular Biology, Qiqihar Medical University, Qiqihar, China |
| Abstract: | The gene coding interleukin 6 (IL-6) is a promising candidate in predisposition to type 2 diabetes mellitus (T2DM). This study aimed to meta-analytically examine the association of IL-6 gene −174G/C polymorphism with T2DM and circulating IL-6 changes across −174G/C genotypes. Odds ratio (OR) and standard mean difference (SMD) with 95% confidence interval (CI) were calculated. Twenty-five articles were meta-analysed, with 20 articles for T2DM risk and 9 articles for circulating IL-6 changes. Overall, there was no detectable significance for the association between −174G/C polymorphism and T2DM, and this association was relatively obvious under dominant model (OR: 0.82, 95% CI: 0.56-1.21). Improved heterogeneity was seen in some subgroups, with statistical significance found in studies involving subjects of mixed races (OR: 0.63, 95% CI: 0.46-0.86). Begg's and filled funnel plots, along with Egger's tests revealed week evidence of publication bias. In genotype-phenotype analyses, carriers of −174CC and −174CG genotypes separately had 0.10 and 0.03 lower concentrations (pg/mL) of circulating IL-6 than −174GG carriers. Albeit no detectable significance for the association of −174G/C with T2DM, our findings provided suggestive evidence on a dose-dependent relation between −174G/C mutant alleles and circulating IL-6 concentrations, indicating possible implication of this polymorphism in the pathogenesis of T2DM. |
| Keywords: | interleukin 6 polymorphism risk type 2 diabetes mellitus |